Lawmakers will debate the FDA’s $3 billion budget and the pharmaceutical industry’s influence on agency funding Sept. 30, according to The New York Times.
Read the full post on Becker's Hospital Review - Healthcare News
FDA’s user fee program up for reauthorization amid concerns about industry influence
